Thailand surrogacy: medical and donor requirements
Thailand’s surrogacy rules are not just a clinic’s medical protocol. The governing framework combines the Protection of Children Born by Medically Assisted Reproductive Technology Act B.E. 2558 (2015), Medical Council standards made under that Act, and the Ministry of Public Health’s case-approval process. The Act requires physical, mental and environmental readiness assessments for intended parents, the surrogate and any sperm or egg donor; it also restricts who may participate, which genetic material may be used, and when treatment can begin. A clinic may apply additional evidence-based screening, but its own policy cannot waive a statutory condition or replace the required committee permission. This guide separates rules supported by the sources from details that still need confirmation against the authoritative Thai text and current professional notices.
Which rules govern the procedure?
The 2015 Act is the baseline cited by the official procedure. The linked English version is expressly unofficial; the Thai text published in the Royal Gazette controls. The current Thai wording and amendment history require confirmation by Thai counsel. The Act uses gendered terms such as “husband and wife” and contains separate couple-eligibility conditions, which are outside this page’s main scope. Medical or donor screening does not establish that a particular couple is eligible; a clinic advertisement or consultation appointment is not legal approval.
Clinical assessment before treatment
Before assisted-reproduction services, section 16 requires assessment of the physical, mental and environmental readiness of applicants, the surrogate and the relevant sperm or oocyte donor. It also requires disease-prevention measures for conditions that may affect the child, under Medical Council rules approved by the statutory committee. The sources do not establish a complete universal laboratory panel. A clinic website’s test list is not itself law. Ask for the current Medical Council notice and the basis for each test, distinguishing statutory requirements, official-form requirements and additional clinic protocol.
Who may provide the service?
The Act requires treatment to be provided by a suitably qualified medical practitioner who follows the applicable Medical Council standards. The official government service page also says surrogacy must take place in a hospital or medical facility certified under the national assisted-reproduction framework. A facility’s ordinary operating licence and its certification for assisted reproductive technology are not necessarily the same document. Before paying or starting stimulation, request the facility’s current licence, ART standards certificate, the name and qualifications of the responsible physician, and written confirmation that the facility can submit a case-specific surrogacy application. A clinic’s general ability to provide IVF does not, by itself, prove that it is authorised to conduct a surrogacy case.
Sperm donor requirements
The official Department of Health Service Support Q&A summarises the Medical Council’s sperm-donation rules as follows: a donor must be aged 20–45 and undergo assessment of physical and mental readiness and environment; if the donor has a lawful wife, her written consent is required. Sperm may not be used for commercial benefit, and the official Q&A states that births resulting from a donor’s donations must be limited to no more than ten families. These details come from an official administrative Q&A last displayed in 2021, not from a full current copy of the underlying notification retrieved. Treat the limits as a strong compliance checklist, but have the clinic confirm the current version, counting method, consent form and records required before any sample is accepted or used.
Egg donor requirements
The same official Q&A describes stricter egg-donor conditions under Medical Council Notification No. 95(9)/2558 (No. 4). In general, a donor must be aged 20–35. A blood relative of the intended wife may be aged 20–40 if the biological relationship is proved by legal documents. The donor must pass physical, mental and environmental readiness assessment and receive counselling about donation risks before the process begins. The Q&A also states that an egg donor must have or have had a lawful husband; where she has a lawful husband, his written consent is required, except for the specified blood-relative donor case. It further states that the intended recipient spouse must have or have had the same nationality as the donor and receive counselling about the risk of chromosomal abnormalities. Only one egg donor may be used in a treatment cycle, and a donor may donate eggs no more than three times. The stated exclusions include a person closely related genetically to the intended husband, the intended wife’s mother or child, and a member of the ART treatment team. Because these rules use gendered marital categories and the full current notice still needs confirmation, confirm each condition with the regulator before relying on it, particularly where marriage equality may affect terminology or application. The same Q&A expressly says that eggs must not be used for commercial benefit.
Embryo composition and genetic testing
Section 22 permits two embryo routes for a surrogacy case: an embryo formed from the intended husband’s sperm and the intended wife’s egg; or an embryo using one of those spouses’ gametes together with another person’s sperm or egg. The section expressly excludes the surrogate’s own egg. On the text available, this is not a route for an embryo made solely from donor sperm and donor eggs with neither intended spouse contributing a gamete. The Act also prohibits an embryo containing genetic material from more than two people. Section 18 allows necessary and appropriate diagnosis of a genetic disease in an embryo, subject to the prescribed rules, but prohibits an act amounting to sex selection. Before treatment, obtain a written embryology plan identifying the source of each gamete, the intended fertilisation method, any genetic testing proposed and the legal basis for it. Do not infer permission from a laboratory’s technical ability to perform a procedure.
Surrogate medical and personal conditions
The statutory surrogacy conditions also affect medical planning. The surrogate must previously have given birth; she cannot be an ascendant or descendant of either intended spouse and, as a rule, must be a blood relative of one of them. The Act allows another woman to be considered where no blood relative is available, but only under the Ministry’s prescribed rules and conditions; do not treat this as an unrestricted option. If the surrogate has a lawful husband or cohabits with a man as husband and wife, the Act requires that person’s consent. The official government procedure page states that the surrogate must be no older than 40 on the date the approval is issued. The statutory text and administrative age condition must be checked together. A clinic’s own preferred age range, obstetric history criteria or risk thresholds may be stricter, but should be labelled as clinical policy rather than presented as a verbatim statutory rule.
The Department of Health Service Support’s Q&A entry dated 14 January 2021 describes additional conditions for a non-relative surrogate: age 20–40; the same nationality as the intended husband or wife under the Q&A’s gendered wording; physical, mental and environmental readiness assessment; and a prior-delivery history of no more than three vaginal births or one caesarean delivery. It also says the surrogate may carry to birth no more than twice and that a non-relative must document her social relationship with the intended parent(s). Written consent from a lawful husband or a man cohabiting with her as husband and wife is required under the Q&A. These details are an older administrative summary, not a verified current notification; confirm how they apply to the particular case, especially if the intended spouses have different nationalities.
Consent, approval and evidence
A surrogacy procedure cannot start merely because a physician and participants have signed private forms. Under section 23, the statutory committee must grant permission for the specific couple and case. The official service guidance says the application is submitted by the provider or responsible service professional through the Department of Health Service Support; regional facilities may use the provincial public-health office. The listed file includes identity and household records, marriage evidence, medical-indication records, readiness assessments for each relevant participant and donor, consent and explanatory forms, the facility’s licence and ART standards certificate, and evidence of the responsible physician’s reproductive-medicine qualifications and appointment. The guidance says the decision period is 60 working days from receipt of a complete application, with extensions of up to 30 working days each, no more than twice. It also says approval is case-specific: a change to the physician, intended spouses, surrogate or sperm/egg requires a new application. Obtain the current official checklist and forms before collecting or translating documents.
Decision matrix: requirement, source and next action
| Area | Requirement to verify |
|---|---|
| Intended couple | Legal marriage and the statutory nationality/infertility conditions must be checked separately from clinical fitness. |
| Surrogate | Prior birth; age no higher than 40 at approval; blood relationship or approved exception. For a non-relative, verify nationality, age 20–40, delivery history, readiness assessment, social-relationship evidence and the stated cap on prior surrogate births. |
| Sperm donor | Age 20–45, readiness assessment, written wife consent where applicable, non-commercial use and family limit. |
| Egg donor | Age 20–35, or 20–40 for qualifying blood relative; screening, counselling, consent and other limits. |
| Embryo and clinic | At least one intended spouse’s gamete, never the surrogate’s egg; qualified clinician, certified facility and prior committee approval. |
Separate legal rules from clinic policy
Use the matrix as a screening aid, not permission to proceed. The Act, the official approval procedure, Medical Council notices and clinic protocols have different legal status. The government procedure helps identify the application file and surrogate-age condition; the HSS Q&A summarizes donor and non-relative-surrogate criteria but is not the underlying notice. Treat details from the unofficial translation or an unread notice as unconfirmed. Ask the clinic to cite the exact law or notice for each mandatory item and label additional medical standards as clinic policy.
Prohibitions and practical risks
Section 41 of the translated Act prohibits purchasing, offering to purchase, selling, importing or exporting sperm, oocytes or embryos; section 40 separately bars embryos containing genetic material from more than two people. Section 22 excludes the surrogate’s own oocyte. Section 25 and implementing rules separately address specified expenses for the surrogate’s health during pregnancy, termination, delivery and postpartum care, including care for the child for at least 30 days; these should not be confused with buying gametes or paying a donor commercially. The proposal does not change the 2015 text unless an amendment has entered into force. Do not arrange cross-border transfer or payment until Thai counsel checks the current Thai text and Gazette history.
The 2026 amendment proposal requires a current status check
Thailand’s marriage-equality legislation took effect on 23 January 2025, but the assisted-reproduction statute still uses gendered terms such as “husband and wife.” The Department of Health Service Support held public consultation on a draft amendment from 2 to 31 July 2026; the proposal would update terminology and address access for same-sex spouses and foreign couples, among other changes. The House of Representatives’ electronic agenda index also lists a Cabinet-sponsored bill as urgent item 77 in the 28th (revised) meeting of the ordinary general session of the 23rd House, year 4. The materials do not establish whether any amendment has since been enacted; the current Royal Gazette text and legislative record must be checked before relying on these rules. Do not assume either that the bill remains only at consultation stage or that its proposed changes are already law. Before treatment, Thai counsel should check the latest parliamentary record, the Royal Gazette and implementing rules. The proposed export change likewise does not override the prohibition in the 2015 text unless an amendment has entered into force.
A safe pre-treatment checklist
Before treatment, ask the provider for a written, case-specific compliance pack: (1) the current statutory and Medical Council provisions relied on; (2) the facility’s operating licence and ART certification; (3) the responsible physician’s qualifications; (4) the medical indication and assessments of physical, mental and environmental readiness for the applicants, surrogate and each donor; (5) signed informed-consent and explanatory forms, including any required spouse consent; (6) proof of a surrogate’s prior birth, age and qualifying relationship or the documented basis for a permitted non-relative exception; (7) a gamete-source and embryo-creation chart; (8) donor eligibility, nationality, donation-count and non-commercial-use records; and (9) the committee’s written approval before treatment. Ask the clinic to mark each item as legislation, official form/notification, or additional clinic policy. Do not proceed while a key requirement is unresolved. The official service page lists no government application fee, but that does not mean medical, laboratory or private-clinic charges are free.
For a non-relative surrogate, also verify the older HSS Q&A’s nationality, age, prior-delivery, readiness-assessment and social-relationship requirements and the stated limit on prior surrogate births; confirm these against current rules.
Sources and verification limits
An English translation is not a substitute for the Thai promulgated text. The administrative Q&A is official guidance, not the full underlying professional notification.
- Protection of a Child Born by Medically Assisted Reproductive Technology Act B.E. 2558 (2015) — unofficial English translation
- Thai Government information portal — procedure for surrogacy approval
- Department of Health Service Support — official donor Q&A
- Parliamentary repository — Medical Council Notification No. 95(9)/2558 (No. 4), B.E. 2563 (2020)
- Department of Health Service Support — draft amendment consultation notice, 16 July 2026
- Thai Government Public Relations Department — Equal Marriage Law effective 23 January 2025
- House of Representatives electronic agenda — Cabinet-sponsored draft amendment listed as urgent item 77
